Allucent has strategically added executives to its C-suite and is deploying artificial intelligence tools to help small and ...

Trial sponsors are typically responsible for providing the experimental drug or treatment at no cost to patients. However, ...

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical ...

GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...

U.S FDA has accepted IND application for COMP360 in PTSD, enabling the initiation of a Phase 2b/3 (COMP202) clinical trial in patients living with PTSD.

MindRank announced last month that it had initiated a Phase 3 clinical trial in China for MDR-001, a small molecule GLP-1 receptor agonists designed with the help of AI. GLP-1 rec ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement of the results from cohort 4 of the randomized, blinded, placebo-controlled ...

Novotech, a globally recognized full-service biotech clinical research organization (CRO), is pleased to announce the appointment of Dr. Anand Tharmaratnam as its new Chief Executive Officer.Dr.

Westcove Partners, LLC ("Westcove"), a highly specialized investment bank, announced that it acted as the exclusive financial ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...